Sotiris Missailidis

Rio De Janeiro, RJ, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Decidual production of interferon lambda in response to ZIKV persistence: Clinical evidence and in vitro modelling.

Decidual production of interferon lambda in response to ZIKV persistence: Clinical evidence and in vitro modelling.

Journal: Heliyon
Published: December 20, 2023

Inhibition of SARS-CoV-2 Infection in Vero Cells by Bovine Lactoferrin under Different Iron-Saturation States.

Inhibition of SARS-CoV-2 Infection in Vero Cells by Bovine Lactoferrin under Different Iron-Saturation States.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 26, 2023

Inactivated and Immunogenic SARS-CoV-2 for Safe Use in Immunoassays and as an Immunization Control for Non-Clinical Trials.

Inactivated and Immunogenic SARS-CoV-2 for Safe Use in Immunoassays and as an Immunization Control for Non-Clinical Trials.

Journal: Viruses
Published: May 15, 2023

Protective Immunity of COVID-19 Vaccination with ChAdOx1 nCoV-19 Following Previous SARS-CoV-2 Infection: A Humoral and Cellular Investigation.

Protective Immunity of COVID-19 Vaccination with ChAdOx1 nCoV-19 Following Previous SARS-CoV-2 Infection: A Humoral and Cellular Investigation.

Journal: Viruses
Published: July 29, 2022

Selection and Characterization of Single-Stranded DNA Aptamers of Diagnostic Potential against the Whole Zika Virus.

Selection and Characterization of Single-Stranded DNA Aptamers of Diagnostic Potential against the Whole Zika Virus.

Journal: Viruses
Published: July 25, 2022

Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug.

Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 08, 2022

Two-Step In Vitro Model to Evaluate the Cellular Immune Response to SARS-CoV-2.

Two-Step In Vitro Model to Evaluate the Cellular Immune Response to SARS-CoV-2.

Journal: Cells
Published: July 29, 2021

Development, Characterization, and In Vivo Evaluation of a Novel Aptamer (Anti-MUC1/Y) for Breast Cancer Therapy.

Development, Characterization, and In Vivo Evaluation of a Novel Aptamer (Anti-MUC1/Y) for Breast Cancer Therapy.

Journal: Pharmaceutics
Published: July 13, 2021

Nanoparticle conjugated with aptamer anti-MUC1/Y for inflammatory arthritis.

Nanoparticle conjugated with aptamer anti-MUC1/Y for inflammatory arthritis.

Journal: Colloids and surfaces. B, Biointerfaces
Published: June 01, 2021

Activation of an Effective Immune Response after Yellow Fever Vaccination Is Associated with the Genetic Background and Early Response of IFN-γ and CLEC5A.

Activation of an Effective Immune Response after Yellow Fever Vaccination Is Associated with the Genetic Background and Early Response of IFN-γ and CLEC5A.

Journal: Viruses
Published: December 15, 2020

Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS-CoV-2): Challenges to Near-Future Breakthroughs.

Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS-CoV-2): Challenges to Near-Future Breakthroughs.

Journal: Journal of immunology research
Published: August 25, 2020

Application of Aptamer-Based Assays to the Diagnosis of Arboviruses Important for Public Health in Brazil.

Application of Aptamer-Based Assays to the Diagnosis of Arboviruses Important for Public Health in Brazil.

Journal: International journal of molecular sciences
Published: April 30, 2020
Showing 1-12 of 29

Last Updated: 09/26/2026